The role of the cyclic peptide backbone in the anti-HIV activity of the cyclotide kalata B1

FEBS Letters

Volumn 574, Issue 1-3, 2004, Pages 69-72

  Daly, Norelle L ^a   Gustafson, Kirk R ^b   Craik, David J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Acyclic permutant; Circular protein; Cyclotide; Cystine knot

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CYCLOPEPTIDE; KALATA B1 PEPTIDE; UNCLASSIFIED DRUG; VEGETABLE PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; DRUG ACTIVITY; DRUG SCREENING; HUMAN IMMUNODEFICIENCY VIRUS; IC 50; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION;

AMINO ACID SEQUENCE; ANTI-HIV AGENTS; CYCLOTIDES; MOLECULAR SEQUENCE DATA; PEPTIDES, CYCLIC; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 4444331457     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2004.08.007     Document Type: Article

References (33)

1. Trabi M., Craik D.J. Trends Biochem. Sci. 27:2002;132-138
2. Craik D.J., Daly N.L., Saska I., Trabi M., Rosengren K.J. J. Bacteriol. 185:2003;4011-4021
3. Craik D.J., Daly N.L., Bond T., Waine C. J. Mol. Biol. 294:1999;1327-1336
4. Göransson U., Luijendijk T., Johansson S., Bohlin L., Claeson P. J. Nat. Prod. 62:1999;283-286
5. Göransson U., Broussalis A.M., Claeson P. Anal. Biochem. 318:2003;107-117
6. Hallock Y.F., Sowder R.C.I., Pannell L.K., Hughes C.B., Johnson D.G., Gulakowski R., Cardellina II J.H., Boyd M.R. J. Org. Chem. 65:2000;124-128
7. Gustafson K.R., Walton L.K., Sowder R.C.I., Johnson D.G., Pannell L.K., Cardellina II J.H., Boyd M.R. J. Nat. Prod. 63:2000;176-178
8. Gustafson K.R., et al. J. Am. Chem. Soc. 116:1994;9337-9338
9. Witherup K.M., Bogusky M.J., Anderson P.S., Ramjit H., Ransom R.W., Wood T., Sardana M. J. Nat. Prod. 57:1994;1619-1625
10. Saether O., Craik D.J., Campbell I.D., Sletten K., Juul J., Norman D.G. Biochemistry. 34:1995;4147-4158
11. Broussalis A.M., Göransson U., Coussio J.D., Ferraro G., Martino V., Claeson P. Phytochemistry. 58:2001;47-51
12. Gran L. Acta Pharmacol. Toxicol. 33:1973;400-408
13. Tam J.P., Lu Y.A., Yang J.L., Chiu K.W. Proc. Natl. Acad. Sci. USA. 96:1999;8913-8918
14. Jennings C., West J., Waine C., Craik D., Anderson M. Proc. Natl. Acad. Sci. USA. 98:2001;10614-10619
15. Daly N.L., Koltay A., Gustafson K.R., Boyd M.R., Casas-Finet J.R., Craik D.J. J. Mol. Biol. 285:1999;333-345
16. Felizmenio-Quimio M.E., Daly N.L., Craik D.J. J. Biol. Chem. 276:2001;22875-22882
17. Rosengren K.J., Daly N.L., Plan M.R., Waine C., Craik D.J. J. Biol. Chem. 278:2003;8606-8616
18. Barry D.G., Daly N.L., Bokesch H.R., Gustafson K.R., Craik D.J. Structure. 12:2004;85-94
19. Pallaghy P.K., Nielsen K.J., Craik D.J., Norton R.S. Protein Sci. 3:1994;1833-1839
20. Schöpke T., Hasan Agha M.I., Kraft R., Otto A., Hiller K. Sci. Pharm. 61:1993;145-153
21. Derua R., Gustafson K.R., Pannell L.K. Biochem. Biophys. Res. Commun. 228:1996;632-638
22. Göransson U., Craik D.J. J. Biol. Chem. 278:2003;48188-48196
23. Daly N.L., Clark R.J., Craik D.J. J. Biol. Chem. 278:2003;6314-6322
24. Daly N.L., Craik D.J. J. Biol. Chem. 275:2000;19068-19075
25. Yasin B., et al. J. Virol. 78:2004;5147-5156
26. Bokesch H.R., Pannell L.K., Cochran P.K., Sowder II R.C., McKee T.C., Boyd M.R. J. Nat. Prod. 64:2001;249-250
27. Craik D.J., Anderson M., Daly N.L. Today's Life Sci. 2003;28-32
28. Craik D.J. Toxicon. 39:2001;1809-1813
29. Craik D.J., Simonsen S., Daly N.L. Curr. Opin. Drug Discov. Devel. 5:2002;251-260
30. Daly N.L., Love S., Alewood P.F., Craik D.J. Biochemistry. 38:1999;10606-10614
31. Schnölzer M., Alewood P., Jones A., Alewood D., Kent S.B.H. Int. J. Pept. Protein Res. 40:1992;180-193
32. Gulakowski R.J., McMahon J.B., Staley P.G., Moran R.A., Boyd M.R. J. Virol. Methods. 33:1991;87-100
33. Barry D.G., Daly N.L., Clark R.J., Sando L., Craik D.J. Biochemistry. 42:2003;6688-6695